← Evidence map

ReviewNature reviews. Clinical oncology2017

A second chance for telomerase reverse transcriptase in anticancer immunotherapy.

Maurizio ZanettiPubMed ↗Publisher ↗

No numbers read from the abstract.

63 papers cite itlatest 60 shown

2017
2018
2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27245281